Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?

Amir Lerman1, David R Holmes, Joerg Herrmann

  • 1Division of Cardiovascular Disease, Department of Internal Medicine, Mayo Clinic and College of Medicine, 200 First Street SW, Rochester, MN 55902, USA. lerman.amir@mayo.edu

European Heart Journal
|March 10, 2007
PubMed

Insights

Microcirculatory dysfunction impacts ST-elevation myocardial infarction outcomes. This review explores its role as a cause or consequence, influencing patient management in acute coronary syndromes.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Clinical Medicine

Background:

  • ST-elevation myocardial infarction (STEMI) treatment aims for myocardial reperfusion, yet success rates remain suboptimal.
  • Normal reperfusion is not achieved in about half of STEMI patients, highlighting unmet clinical needs.
  • The coronary microcirculation's role in STEMI pathophysiology and outcomes is increasingly recognized.

Purpose of the Study:

  • To review the critical role of coronary microcirculation in the development and clinical outcomes of STEMI.
  • To synthesize current understanding of microcirculatory dysfunction in acute coronary syndromes.
  • To discuss the implications of microcirculatory dysfunction for patient management strategies.

Main Methods:

  • A comprehensive literature search was conducted using PubMed/Medline.
  • Key search terms included: acute coronary syndrome, acute myocardial infarction, coronary artery disease, endothelial dysfunction, microcirculation, and reperfusion.
  • Information synthesis focused on understanding the dual theories of microcirculatory dysfunction in STEMI.

Main Results:

  • Evidence suggests myocardial microcirculatory dysfunction can be a consequence of primary epicardial events (vulnerable plaque concept).
  • Alternatively, microcirculatory dysfunction may contribute to the acute coronary event's course (vulnerable patient concept).
  • The study discusses the merits of both viewpoints and their impact on clinical decision-making.

Conclusions:

  • Microcirculatory dysfunction in STEMI can be viewed as a cause, a consequence, or a combination of both.
  • Understanding these mechanisms is crucial for refining treatment strategies in acute myocardial infarction.
  • This review underscores the complexity of microcirculatory involvement in STEMI, bridging traditional and non-traditional concepts.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...